LB Pharmaceuticals Inc (LBRX)

LB Pharmaceuticals Statistics

Total Valuation

LBRX has a market cap or net worth of $803.81 million. The enterprise value is $441.64 million.

Market Cap	803.81M
Enterprise Value	441.64M

Important Dates

The last earnings date was Tuesday, May 12, 2026, after market close.

Earnings Date	May 12, 2026
Ex-Dividend Date	n/a

Share Statistics

LBRX has 28.68 million shares outstanding. The number of shares has increased by 4,085.30% in one year.

Current Share Class	28.68M
Shares Outstanding	28.68M
Shares Change (YoY)	+4,085.30%
Shares Change (QoQ)	+11.16%
Owned by Insiders (%)	0.82%
Owned by Institutions (%)	71.15%
Float	18.10M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	2.12
P/TBV Ratio	2.12
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 35.68, with a Debt / Equity ratio of 0.01.

Current Ratio	35.68
Quick Ratio	33.53
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -19.55% and return on invested capital (ROIC) is -13.89%.

Return on Equity (ROE)	-19.55%
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	-13.89%
Return on Capital Employed (ROCE)	-11.78%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	-$1.11M
Employee Count	35
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, LBRX has paid $1,000 in taxes.

Income Tax	1,000
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	27.98
200-Day Moving Average	n/a
Relative Strength Index (RSI)	42.73
Average Volume (20 Days)	151,607

Short Selling Information

The latest short interest is 3.80 million, so 13.25% of the outstanding shares have been sold short.

Short Interest	3.80M
Short Previous Month	3.11M
Short % of Shares Out	13.25%
Short % of Float	20.99%
Short Ratio (days to cover)	12.71

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-45.08M
Pretax Income	-38.95M
Net Income	-38.95M
EBITDA	-44.76M
EBIT	-45.08M
Earnings Per Share (EPS)	-$2.59

Balance Sheet

The company has $365.64 million in cash and $3.47 million in debt, with a net cash position of $362.17 million or $12.63 per share.

Cash & Cash Equivalents	365.64M
Total Debt	3.47M
Net Cash	362.17M
Net Cash Per Share	$12.63
Equity (Book Value)	378.69M
Book Value Per Share	13.21
Working Capital	378.17M

Cash Flow

In the last 12 months, operating cash flow was -$50.37 million and capital expenditures -$63,000, giving a free cash flow of -$50.43 million.

Operating Cash Flow	-50.37M
Capital Expenditures	-63,000
Depreciation & Amortization	324,000
Net Borrowing	n/a
Free Cash Flow	-50.43M
FCF Per Share	-$1.76

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

LBRX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-4,085.30%
Shareholder Yield	-4,085.30%
Earnings Yield	-4.85%
FCF Yield	-6.27%

Analyst Forecast

The average price target for LBRX is $45.00, which is 60.37% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$45.00
Price Target Difference	60.37%
Analyst Consensus	Strong Buy
Analyst Count	6
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a